Biopharma companies encounter crucial commercial barriers as they navigate their assets from molecule to marketplace. In a contemporary landscape where product types and therapies are diversifying, biopharma companies are searching for commercial partnerships that understand and address their unique needs rather than a one-size-fits-all model. During this session, Cencora experts will address the interdependent challenges biopharma companies face and provide strategies that orchestrate efforts across the industry to maximize the use of capital and drive commercial success. Sponsored by: Cencora